Validation of a Rapid Screening Tool for Anxiety-Depressive Disorders in Children, Adolescents, and Young Adults Treated in Oncology

What this Trial Is About

Researchers are evaluating a new rapid screening tool designed to detect anxiety and depressive disorders in children, adolescents, and young adults who have survived childhood cancer. This study recognizes that psychological health can be significantly affected in this population, with previous research showing higher rates of anxiety symptoms compared to the general population. The goal is to create a quick and easy test that oncologists can use routinely during follow-up visits to identify individuals who may need more detailed psychological evaluation. The study involves completing different questionnaires depending on age groups during regular follow-up consultations. Children aged 7 to 14 will complete the new rapid screening tool along with the SCARED-R-51 questionnaire, while young adults aged 15 to 25 will complete the new tool and the HADS questionnaire. These tools are being developed and validated using psychometric methods to ensure their effectiveness in screening for psychological disorders. Participants will be evaluated at the time of inclusion through these questionnaires during their usual follow-up visits. The research team will compare responses to assess the new tool's accuracy and reliability. The study is multicenter and observational, with participants ranging from 7 to 25 years old who are in remission after pediatric cancer treatment. The primary outcome is the performance of the new rapid screening tool compared to established anxiety and depression scales.

Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.